Ranbaxy launches generic Caduet in US

Ranbaxy launches generic Caduet in US
Comment E-mail Print Share
First Published: Tue, Dec 06 2011. 04 27 PM IST

Caduet pills make their way through the manufacturing process at one of Pfizer’s manufacturing facilities. Photo: Bloomberg
Caduet pills make their way through the manufacturing process at one of Pfizer’s manufacturing facilities. Photo: Bloomberg
Updated: Tue, Dec 06 2011. 04 27 PM IST
Caduet pills make their way through the manufacturing process at one of Pfizer’s manufacturing facilities. Photo: Bloomberg
Mumbai: Drugmaker Ranbaxy Laboratories said on Tuesday its unit has launched a generic version of Pfizer’s blood pressure- and cholesterol-lowering drug Caduet in the United States (US) following an agreement between the two companies.
Caduet has annual sales of $339 million in the US, Ranbaxy said in a statement.
The terms of the agreement were not disclosed.
Ranbaxy, majority-owned by Japan’s Daiichi Sankyo, last week launched a generic version of Lipitor, the world’s top selling drug, which is also a Pfizer brand.
Comment E-mail Print Share
First Published: Tue, Dec 06 2011. 04 27 PM IST
More Topics: Ranbaxy | Drugmaker | Pharmaceuticals | US | Pfizer |